[Histopathological diagnostic work-up of joint endoprosthesis-associated pathologies].
Identifieur interne : 000912 ( Ncbi/Curation ); précédent : 000911; suivant : 000913[Histopathological diagnostic work-up of joint endoprosthesis-associated pathologies].
Auteurs : V. Krenn [Allemagne] ; G. Perino [États-Unis] ; V T Krenn [Allemagne] ; S. Wienert [Allemagne] ; D. Saberi [Allemagne] ; T. Hügle [Suisse] ; F. Hopf [Allemagne] ; M. Huber [Autriche]Source :
- Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete [ 1432-1173 ] ; 2016.
Abstract
Increasing classes of joint implants and the combination of materials results in increased and wear-associated pathologies. According to the revised consensus classification, the following types can be recognized at conventional histological examination: Type I, particle-induced type; Type II, infection type; Type III, combination type; Type IV, indifferent type; Type V arthrofibrotic type; Type VI, allergic/immunological/toxic adverse reactions and Type VII, bone pathologies. Wear particles are histopathologically characterized according to the Krenn particle algorithm which focuses on a descriptive identification of wear particles and the differentiation of other nonwear-related particles. Type VII is considered histologically when there is evidence of a perivascular/interstitial lymphocytic CD20- and CD3-positive infiltrate, presence of mast cells and eosinophils, and tissue necrosis/infarction associated with implant wear material. Since wear particle-induced toxicity cannot be differentiated with certainty from hypersensitivity/allergic reaction on histological examination, immunological-allergological and clinical data should be used as supplementary criteria for the differential diagnosis. Tissue sampling should be performed from periprosthetic soft tissue with location mapping and when feasible also from bone tissue. Additional information regarding the type of implant and clinical, radiological, immunological, and microbiology data should be available to the pathologist. Further immunohistochemical studies are recommended in the following settings: infection (CD15, CD20, CD68); prosthesis-associated arthrofibrosis (β‑catenin); allergic/immunologic/toxic adverse reactions (CD20, CD3, CD4, CD8, CD117 and for T‑cell characterization T‑bet, GATA-3, and FOXP3).
DOI: 10.1007/s00105-016-3778-2
PubMed: 26987961
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000145
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :000145
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000145
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000912
Links to Exploration step
pubmed:26987961Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Histopathological diagnostic work-up of joint endoprosthesis-associated pathologies].</title>
<author><name sortKey="Krenn, V" sort="Krenn, V" uniqKey="Krenn V" first="V" last="Krenn">V. Krenn</name>
<affiliation wicri:level="1"><nlm:affiliation>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier, Deutschland. krenn@patho-trier.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier</wicri:regionArea>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>Trier</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Perino, G" sort="Perino, G" uniqKey="Perino G" first="G" last="Perino">G. Perino</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Krenn, V T" sort="Krenn, V T" uniqKey="Krenn V" first="V T" last="Krenn">V T Krenn</name>
<affiliation wicri:level="3"><nlm:affiliation>Sigmund Freud PrivatUniversität Berlin, Berlin, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Sigmund Freud PrivatUniversität Berlin, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wienert, S" sort="Wienert, S" uniqKey="Wienert S" first="S" last="Wienert">S. Wienert</name>
<affiliation wicri:level="3"><nlm:affiliation>VMscope GmbH Berlin, Berlin, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>VMscope GmbH Berlin, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Saberi, D" sort="Saberi, D" uniqKey="Saberi D" first="D" last="Saberi">D. Saberi</name>
<affiliation wicri:level="1"><nlm:affiliation>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier</wicri:regionArea>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>Trier</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hugle, T" sort="Hugle, T" uniqKey="Hugle T" first="T" last="Hügle">T. Hügle</name>
<affiliation wicri:level="1"><nlm:affiliation>Universitätsspital Basel, Basel, Schweiz.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Universitätsspital Basel, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hopf, F" sort="Hopf, F" uniqKey="Hopf F" first="F" last="Hopf">F. Hopf</name>
<affiliation wicri:level="1"><nlm:affiliation>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier</wicri:regionArea>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>Trier</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Huber, M" sort="Huber, M" uniqKey="Huber M" first="M" last="Huber">M. Huber</name>
<affiliation wicri:level="3"><nlm:affiliation>Pathologisch-bakteriologisches Institut, Otto Wagner Spital, Wien, Österreich.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Pathologisch-bakteriologisches Institut, Otto Wagner Spital, Wien</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26987961</idno>
<idno type="pmid">26987961</idno>
<idno type="doi">10.1007/s00105-016-3778-2</idno>
<idno type="wicri:Area/PubMed/Corpus">000145</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000145</idno>
<idno type="wicri:Area/PubMed/Curation">000145</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000145</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000145</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000145</idno>
<idno type="wicri:Area/Ncbi/Merge">000912</idno>
<idno type="wicri:Area/Ncbi/Curation">000912</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Histopathological diagnostic work-up of joint endoprosthesis-associated pathologies].</title>
<author><name sortKey="Krenn, V" sort="Krenn, V" uniqKey="Krenn V" first="V" last="Krenn">V. Krenn</name>
<affiliation wicri:level="1"><nlm:affiliation>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier, Deutschland. krenn@patho-trier.de.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier</wicri:regionArea>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>Trier</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Perino, G" sort="Perino, G" uniqKey="Perino G" first="G" last="Perino">G. Perino</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Pathology and Laboratory Medicine, Hospital for Special Surgery, New York</wicri:regionArea>
<placeName><region type="state">État de New York</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Krenn, V T" sort="Krenn, V T" uniqKey="Krenn V" first="V T" last="Krenn">V T Krenn</name>
<affiliation wicri:level="3"><nlm:affiliation>Sigmund Freud PrivatUniversität Berlin, Berlin, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Sigmund Freud PrivatUniversität Berlin, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Wienert, S" sort="Wienert, S" uniqKey="Wienert S" first="S" last="Wienert">S. Wienert</name>
<affiliation wicri:level="3"><nlm:affiliation>VMscope GmbH Berlin, Berlin, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>VMscope GmbH Berlin, Berlin</wicri:regionArea>
<placeName><region type="land" nuts="3">Berlin</region>
<settlement type="city">Berlin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Saberi, D" sort="Saberi, D" uniqKey="Saberi D" first="D" last="Saberi">D. Saberi</name>
<affiliation wicri:level="1"><nlm:affiliation>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier</wicri:regionArea>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>Trier</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hugle, T" sort="Hugle, T" uniqKey="Hugle T" first="T" last="Hügle">T. Hügle</name>
<affiliation wicri:level="1"><nlm:affiliation>Universitätsspital Basel, Basel, Schweiz.</nlm:affiliation>
<country xml:lang="fr">Suisse</country>
<wicri:regionArea>Universitätsspital Basel, Basel</wicri:regionArea>
<wicri:noRegion>Basel</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Hopf, F" sort="Hopf, F" uniqKey="Hopf F" first="F" last="Hopf">F. Hopf</name>
<affiliation wicri:level="1"><nlm:affiliation>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier, Deutschland.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>MVZ-Zentrum für Histologie, Zytologie und Molekulare Diagnostik, Max-Planck-Str. 5, 54296, Trier</wicri:regionArea>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>54296, Trier</wicri:noRegion>
<wicri:noRegion>Trier</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Huber, M" sort="Huber, M" uniqKey="Huber M" first="M" last="Huber">M. Huber</name>
<affiliation wicri:level="3"><nlm:affiliation>Pathologisch-bakteriologisches Institut, Otto Wagner Spital, Wien, Österreich.</nlm:affiliation>
<country xml:lang="fr">Autriche</country>
<wicri:regionArea>Pathologisch-bakteriologisches Institut, Otto Wagner Spital, Wien</wicri:regionArea>
<placeName><settlement type="city">Vienne (Autriche)</settlement>
<region nuts="2" type="province">Vienne (Autriche)</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete</title>
<idno type="eISSN">1432-1173</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Increasing classes of joint implants and the combination of materials results in increased and wear-associated pathologies. According to the revised consensus classification, the following types can be recognized at conventional histological examination: Type I, particle-induced type; Type II, infection type; Type III, combination type; Type IV, indifferent type; Type V arthrofibrotic type; Type VI, allergic/immunological/toxic adverse reactions and Type VII, bone pathologies. Wear particles are histopathologically characterized according to the Krenn particle algorithm which focuses on a descriptive identification of wear particles and the differentiation of other nonwear-related particles. Type VII is considered histologically when there is evidence of a perivascular/interstitial lymphocytic CD20- and CD3-positive infiltrate, presence of mast cells and eosinophils, and tissue necrosis/infarction associated with implant wear material. Since wear particle-induced toxicity cannot be differentiated with certainty from hypersensitivity/allergic reaction on histological examination, immunological-allergological and clinical data should be used as supplementary criteria for the differential diagnosis. Tissue sampling should be performed from periprosthetic soft tissue with location mapping and when feasible also from bone tissue. Additional information regarding the type of implant and clinical, radiological, immunological, and microbiology data should be available to the pathologist. Further immunohistochemical studies are recommended in the following settings: infection (CD15, CD20, CD68); prosthesis-associated arthrofibrosis (β‑catenin); allergic/immunologic/toxic adverse reactions (CD20, CD3, CD4, CD8, CD117 and for T‑cell characterization T‑bet, GATA-3, and FOXP3).</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Rhénanie/explor/UnivTrevesV1/Data/Ncbi/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000912 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd -nk 000912 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Rhénanie |area= UnivTrevesV1 |flux= Ncbi |étape= Curation |type= RBID |clé= pubmed:26987961 |texte= [Histopathological diagnostic work-up of joint endoprosthesis-associated pathologies]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Curation/RBID.i -Sk "pubmed:26987961" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Curation/biblio.hfd \ | NlmPubMed2Wicri -a UnivTrevesV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |